Evox Therapeutics

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. Dot Compliance upgrades AI-powered life sciences eQMS system, Dottie AI The system utilises generative and predictive AI to streamline and optimise the quality management process for customers in the pharmaceutical, biotech and medical device...
  3. HOOKIPA Pharma begins non-binding discussions to acquire Poolbeg Pharma The two pharmaceutical companies may create a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation immunotherapies
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Drug Delivery

Evox announces collaboration to work on AAV vectors as novel gene technology

Evox has entered into a research collaboration for developing exosome-encapsulated AAV (exoAAV) vectors with the Icahn School of Medicine at Mount Sinai in New York
Research & Development

Evox Therapeutics and Takeda sign multitarget rare disease collaboration

Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox’s proprietary exosome technology
Recruitment

Evox hires two experienced new VPs

Bo Kara will take over VP of Process Development and Simon Dew will be VP of Business Development
Finance

Research funding round-up

Capital to support the development of new drugs and technology around the world
Research & Development

Evox Therapeutics to expand its work on cell-targeted delivery of nucleic acid-based drugs

Funding received from the Bill & Melinda Gates Foundation
Finance

Evox Therapeutics wins funding to explore exosome-mediated delivery of dystrophin

Targeted delivery of dystrophin has the potential to be a highly effective treatment for Duchenne muscular dystrophy
Research & Development

Evox expands exosome platform for drug delivery

The therapeutics company has rasied £35.5 million of new capital to fund the project
Subscribe now